BD appoints Garrison as Medical segment president and Byrd as Interventional segment president; Campion departs

BECTON DICKINSON & CO

Michael Garrison named EVP & President, Medical segment, effective Sept 6, 2022; previously led Medication Management Solutions.
Richard Byrd named EVP & President, Interventional segment, effective Sept 6, 2022; previously led Medication Delivery Solutions.
Simon Campion to depart BD on Sept 9, 2022 for executive role elsewhere; he joined via C.R. Bard acquisition.
Both Garrison and Byrd report to CEO Tom Polen and join Executive Leadership Team.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Garrison

Executive Vice President and President, Medical Segment

BDX · BECTON DICKINSON & CO

Effective: 2022-09-06
Filed: August 25, 2022, 7:59 PM ET

Michael Garrison has been named BD's Executive Vice President and President, Medical Segment

Appointed

Richard Byrd

Executive Vice President and President, Interventional Segment

BDX · BECTON DICKINSON & CO

Effective: 2022-09-06
Filed: August 25, 2022, 7:59 PM ET

Richard Byrd has been named BD's Executive Vice President and President, Interventional Segment

Departed

Simon Campion

Executive Vice President and President, Medical Segment

BDX · BECTON DICKINSON & CO

Effective: 2022-09-09
Successor: Michael Garrison
Filed: August 25, 2022, 7:59 PM ET

Simon Campion informed BD that he will depart BD on September 9, 2022 for an executive role in the health care industry.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Garrison was named as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.

Action: named
Role: Executive Vice President and President, Medical Segment

Exact text from the filing

Michael Garrison has been named BD's Executive Vice President and President, Medical Segment

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Richard Byrd was named as Executive Vice President and President, Interventional Segment at BECTON DICKINSON & CO.

Action: named
Role: Executive Vice President and President, Interventional Segment

Exact text from the filing

Richard Byrd has been named BD's Executive Vice President and President, Interventional Segment

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Simon Campion departed as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.

Action: departed
Role: Executive Vice President and President, Medical Segment

Exact text from the filing

Simon Campion informed BD that he will depart BD on September 9, 2022 for an executive role in the health care industry.

View on SEC.gov

BECTON DICKINSON & CO filing history →

Source: SEC EDGAR

accession 0000010795-22-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.